Niranjan Kanesa-Thasan - 31 May 2022 Form 5 Insider Report for Icosavax, Inc.

Role
Chief Medical Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 May 2022
Net transactions value
+$9,619
Form type
5
Filing time
14 Feb 2023, 16:19:42 UTC
Previous filing
14 Feb 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $9,619 +1,667 +0.7% $5.77 240,981 31 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022 by the Reporting person in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).